Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 945-950

  Quade, Bradley J ^a,b   Pinto, Álvaro P ^a,c   Howard, Donald R ^d   Peters III, William A ^e   Crum, Christopher P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 10; CHROMOSOME MARKER; CHROMOSOME POLYMORPHISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERUS MYOMA;

EID: 0032998422     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65342-4     Document Type: Article

References (50)

1. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438
2. Pokras P, Hunfnagel VG: Hysterectomies in the United States, 1965-84. Series 13, No. 92: Vital and Health Statistics. Washington, DC, Government Printing Office, 1987
3. Zaloudek C, Norris HJ: Mesenchymal tumors of the uterus. Pathology of the Female Genital Tract. Edited by RJ Kurman. New York. Springer-Verlag, 1994, pp 487-528
4. Bell SW, Kempson RL, Hendrickson MR: Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases. Am J Surg Pathol 1994, 18:535-558
5. Quade BJ: Pathology, cytogenetics, and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 1995, 7:35-42
6. Boghosian L, Dal Cin P, Turc-Carel C, Rao U, Karakousis C, Sait SJ, Sandberg AA: Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet 1989, 43:39-49
7. Fletcher JA, Morton CC, Paelka K, Lage JM: Chromosome aberration in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res 1990 50:4092-4097
8. Laxman R, Currie JL, Kurman RJ, Dudzinski M, Griffin A: Cytogenetic profile of uterine sarcomas. Cancer 1993, 71:1283-1288
9. Nilbert M, Mandahl N, Heim S, Rydholm A, Willen H, Akerman M, Mitelman F: Chromosome abnormalities in leiomyosarcomas. Cancer Genet Cytogenet 1988, 34:209-218
10. Nilbert M, Mandahl N, Heim S, Rydholm A, Helm G, Willen H, Baldetorp B, Mitelman F: Complex karyotypic changes, including rearrangements of 12q13 and 14q24, in two leiomyosarcoma. Cancer Genet Cytogenet 1990, 48:217-223
11. Sait SNJ, Dal Cin P, Sandberg AA: Consistent chromosome changes in leiomyosarcoma. Cancer Genet Cytogenet 1988, 35:47-50
12. Sreekantaiah C, Davis JR, Sandberg AA: Chromosomal abnormalities in leiomyosarcomas. Am J Pathol 1993, 142:293-305
13. Meloni AM, Surti U, Contento AM, Davare J, Sandberg AA: Uterine leiomyomas: cytogenetic and histologic profile. Obstet Gynecol 1992, 80:209-217
14. Pandis N, Heim S, Bardi G, Flodérus U-M, Willén H, Mandahl N, Mitelman F: Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet 1991, 55:11-18
15. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC: Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991, 77:923-926
16. Heim S, Nilbert M, Vanni R, Flodérus U-M, Mandahl N, Liedgren S, Lecca U, Mitelman F: A specific translocation, t(12;14)(q14-15;q23-24), characterizes a subgroup of uterine leiomyomas Cancer Genet Cytogenet 1988, 32:13-17
17. Ozisik YY, Meloni AM, Surti U, Sandberg AA: Deletion 7q22 in uterine leiomyoma: a cytogenetic review. Cancer Genet Cytogenet 1993, 71:1-6
18. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon SJ, Kucherlapati RS, Chada K, Morton CC: Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes Cancer 1996, 17:1-6
19. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ: Recurrent rearrangements in the high mobility group protein gene. HMGI-C, in benign mesenchymal tumours. Nat Genet 1995, 10:436-443
20. Pedeutour F, Quade BJ, Weremowicz S, Dal Cin P, Ali S, Morton CC: Localization and expression of the human estrogen receptor β gene in uterine leiomyomata. Genes Chromosomes Cancer 1998, 23:361-366
21. Van de Ven WJ, Schoenmakers EF, Wanschura S, Kazmierczak B, Kools PF, Geurts JM, Bartnitzke S, Van den Berghe H, Bullerdiek J: Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer 1995, 12:296-303
22. Nilbert M, Heim S, Mandahl N, Foldrus UM, Willén H, Mitelman F: Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 1990, 85:605-611
23. Nilbert M, Heim S, Mandahl N, Flodérus U-M, Willén H, Mitelman F: Trisomy 12 in uterine leiomyomas: a new cytogenetic subgroup. Cancer Genet Cytogenet 1990, 45:63-66
24. Ozisik YY, Meloni AM, Surti U, Sandberg AA: Involvement of 10q22 in leiomyoma. Cancer Genet Cytogenet 1993, 69:132-135
25. Ozisik YY, Meloni AM, Altungoz O, Surti U, Sandberg AA: Translocation (6;10)(p21:q22) in uterine leiomyomas. Cancer Genet Cytogenet 1995, 79:136-138
26. Williams AJ, Powell WL, Collins T, Morton CC: HMGI(Y) expression in human uterine leiomyomata: involvement of another high-mobility group architectural factor in a benign neoplasm. Am J Pathol 1997, 150:911-918
27. Karaiskos C, Pandis N, Bardi G, Sfikas K, Tserkezoglou A, Fotiou S, Heim S: Cytogenetic findings in uterine epithelioid leiomyomas. Cancer Genet Cytogenet 1995, 80:103-106
28. Havel G, Wedell B, Dahlenfors R, Mark J: Cytogenetic relationship between uterine lipoleiomyomas and typical leiomyomas. Virchows Arch B Cell Pathol 1989, 57:77-79
29. Hu J, Surti U, Tobon H: Cytogenetic analysis of a uterine lipoleiomyoma. Cancer Genet Cytogenet 1992, 62:200-202
30. Ozisik YY, Meloni AM, Sandberg AA, Surti U, Tobon H, Devare J: Cytogenetic findings in a symplastic leiomyoma. Cancer Genet Cytogenet 1993, 67:79-80
31. Nilbert M, Heim S, Mandahl N, Flodérus U-M, Willén H, Baldetorp B, Mitelman F: Complex karyotypic anomalies in a bizarre leiomyoma of the uterus. Genes Chromosomes Cancer 1989, 1:131-134
32. Peters III WA, Howard DR, Andersen WA, Figge DC: Uterine smooth-muscle tumors of uncertain malignant potential. Obstet Gynecol 1994, 83:1015-1020
33. Peters III WA, Howard DR, Andersen WA, Figge DC: DNA analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential. Am J Obstet Gynecol 1992, 166:1646-1654
34. Lin MC, Mutter GL, Trivijisilp P, Boynton KA, Sun D, Crum CP: Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Am J Pathol 1998, 152:1313-1318
35. Mutter GL, Boynton KA, Faquin WC, Ruiz RE, Jovanovic AS: Allelo-type mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res 1996, 56:4483-4486
36. Ozisik YY, Meloni AM, Surti U, Sandberg AA: Deletion 7q22 in uterine leiomyoma: a cytogenetic review. Cancer Genet Cytogenet 1993, 71:1-6
37. Everitt JI, Wolf DC, Howe SR, Goldsworthy TL, Walker C: Rodent model of reproductive tract leiomyomata: clinical and pathological features. Am J Pathol 1995, 146:1556-1567
38. Kubo Y, Kikuchi Y, Milani H, Kobayashi E, Kobayashi T, Hino O: Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model. Jpn J Cancer Res 1995, 86:828-832
39. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MPKDJ Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 1995, 13:295-298
40. Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJFD, Gillett G, Malas S, Robson EB, Tippelt P, Edwards JH, Kwiatkowski DJ, Super M, Mueller R, Fryer A, Clarke A, Webb D, Osborne J: Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 1994, 58:107-127
41. Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG: Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 1994, 91:11413-11416
42. Ishwad CS, Ferrell RE, Davare J, Meloni AM, Sandberg AA, Surti U: Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosomes Cancer 1995, 14:51-55
43. Packenham JP, du MS, Schrock E, Risinger JI, Dixon D, Denz DN, Evans JA, Berchuck A, Barrett JC, Devereux TR, Ried T: Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog 1997, 19:273-279
44. El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol 1998, 153:985-990
45. Kiechle-Schwarz M, Berger CS, Surti U, Sandberg AA: Rearrangement of band 10q22 in leiomyoma and leiomyosarcoma of the uterus. Cancer Genet Cytogenet 1990, 47:95-100
46. Dal Cin P, Boghosian L, Crickard K, Sandberg AA: t(10;17) as the sole chromosome change in a uterine leiomyosarcoma. Cancer Genet Cytogenet 1988, 32:263-266
47. Nilbert M, Jin YS, Heim S, Mandahl N, Floderus UM, Willer H, Mitelman F: Chromosome rearrangements in two uterine sarcomas Cancer Genet Cytogenet 1990, 44:27-35
48. Bostrom J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G: Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res 1998, 58:29-33
49. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV: Identification of a cand date tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362
50. Risinger JI, Hayes AK, Berchuck A, Barrett JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997, 57:4736-4738